155 related articles for article (PubMed ID: 36207643)
1. Clinical Validation of the Covariates Pharmacokinetic Model for Propofol in an Adult Population.
Hawthorne C; Shaw M; Campbell R; Sutcliffe N; McKelvie S; Schraag S
Drugs R D; 2022 Dec; 22(4):289-300. PubMed ID: 36207643
[TBL] [Abstract][Full Text] [Related]
2. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
[TBL] [Abstract][Full Text] [Related]
3. Use of target controlled infusion to derive age and gender covariates for propofol clearance.
White M; Kenny GN; Schraag S
Clin Pharmacokinet; 2008; 47(2):119-27. PubMed ID: 18193918
[TBL] [Abstract][Full Text] [Related]
4. External Validation of a Pharmacokinetic Model of Propofol for Target-Controlled Infusion in Children under Two Years Old.
Ji SH; Lee JH; Cho JY; Kim HS; Jang YE; Kim EH; Kim JT; Kim HS
J Korean Med Sci; 2020 Mar; 35(11):e70. PubMed ID: 32193901
[TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic model optimized by covariates for propofol target-controlled infusion in dogs.
Cattai A; Bizzotto R; Cagnardi P; Di Cesare F; Franci P
Vet Anaesth Analg; 2019 Sep; 46(5):568-578. PubMed ID: 31326349
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the performance of the Marsh model in effect site mode for target controlled infusion of propofol during the maintenance phase of general anaesthesia in an unselected population of neurosurgical patients.
Cowley NJ; Hutton P; Clutton-Brock TH
Eur J Anaesthesiol; 2013 Oct; 30(10):627-32. PubMed ID: 23962821
[TBL] [Abstract][Full Text] [Related]
7. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
Eleveld DJ; Colin P; Absalom AR; Struys MMRF
Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
[TBL] [Abstract][Full Text] [Related]
9. Predictive accuracy of continuous propofol infusions in neurosurgical patients: comparison of pharmacokinetic models.
Hans P; Coussaert E; Cantraine F; Pieron F; Dewandre PY; d'Hollander A; Lamy M
J Neurosurg Anesthesiol; 1997 Apr; 9(2):112-7. PubMed ID: 9100179
[TBL] [Abstract][Full Text] [Related]
10. Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia.
Hara M; Masui K; Eleveld DJ; Struys MMRF; Uchida O
Br J Anaesth; 2017 Mar; 118(3):415-423. PubMed ID: 28186264
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the predictive performance of three pharmacokinetic models for propofol using measured values obtained during target-controlled infusion.
Glen JB; White M
Anaesthesia; 2014 Jun; 69(6):550-7. PubMed ID: 24720380
[TBL] [Abstract][Full Text] [Related]
12. Predictive performance of a new pharmacokinetic model for propofol in underweight patients during target-controlled infusion.
Yi JM; Doh I; Lee SH; Kim SY; Lee YH; Lee EK; Lee SH; Choi BM; Noh GJ
Acta Anaesthesiol Scand; 2019 Apr; 63(4):448-454. PubMed ID: 30690713
[TBL] [Abstract][Full Text] [Related]
13. External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia.
Lee S; Kang D; Song E; Yoo S; Jeong S
BMC Anesthesiol; 2024 Feb; 24(1):70. PubMed ID: 38395779
[TBL] [Abstract][Full Text] [Related]
14. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bias in predicted and measured propofol concentrations during target-controlled infusions in obese Japanese patients: an open-label comparative study.
Tachibana N; Niiyama Y; Yamakage M
Eur J Anaesthesiol; 2014 Dec; 31(12):701-7. PubMed ID: 25192266
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children.
Choi BM; Lee HG; Byon HJ; Lee SH; Lee EK; Kim HS; Noh GJ
J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):163-77. PubMed ID: 25724290
[TBL] [Abstract][Full Text] [Related]
17. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia.
Mertens MJ; Engbers FH; Burm AG; Vuyk J
Br J Anaesth; 2003 Feb; 90(2):132-41. PubMed ID: 12538367
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and optimisation of propofol pharmacokinetic parameters in cats for target-controlled infusion.
Cattai A; Pilla T; Cagnardi P; Zonca A; Franci P
Vet Rec; 2016 May; 178(20):503. PubMed ID: 27044652
[TBL] [Abstract][Full Text] [Related]
19. Clinical adaptation of a pharmacokinetic model of Propofol plasma concentrations in children.
Engelhardt T; McCheyne AJ; Morton N; Karsli C; Luginbuehl I; Adeli K; Walsh W; Bissonnette B
Paediatr Anaesth; 2008 Mar; 18(3):235-9. PubMed ID: 18179618
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of propofol during conscious sedation using target-controlled infusion in anxious patients undergoing dental treatment.
Oei-Lim VL; White M; Kalkman CJ; Engbers FH; Makkes PC; Ooms WG
Br J Anaesth; 1998 Mar; 80(3):324-31. PubMed ID: 9623432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
